News | August 04, 2011

Study: Positron Emission Mammography (PEM) May Help Predict Breast Cancer Survival

August 4, 2011 – Published last week in The American Journal of Roentgenology, researchers from Swedish Cancer Institute and the University of Washington used positron emission mammography (PEM) to find a correlation between fludeoxyglucose (FDG) uptake values and the prognostic factors that predict breast cancer survival. The highest FDG levels were in the most aggressive cancer type – triple negative cancers. Women with triple negative breast cancer have a higher mortality because there is no tailored therapy available to them. PEM may now benefit this patient population as it may help identify when a chemotherapeutic regimen is not working. PEM also has the potential to play a role in initial staging of breast cancer in patients at high risk for multifocal or multicentric disease who desire breast conservation therapy as an alternative to breast MRI.

PEM is the breast application of the Naviscan high-resolution PET scanner showing the location as well as the metabolic phase of a lesion. It is the only U.S Food and Drug Administration (FDA)-cleared 3-D molecular breast imaging (MBI) device on the market. The metabolic view assists physicians in making optimal care decisions by providing an ability to distinguish between benign and malignant lesions, what researchers term "specificity."

Histologic grade, tumor size and expression of estrogen receptor (ER), progesterone receptor (PR) and HER2/neu receptor are considered important prognostic variables in the clinical management of breast cancer. According to the publication authors, this is the first study to evaluate the correlation between prognostic indicators and FDG uptake values on PEM.

"PEM shows a significant positive correlation between FDG uptake and various prognostic factors since the advent of hormonal therapy such as hormone receptor status and histologic grade," stated Carolyn Wang, M.D., the lead author of the paper. "Lesion to background (LTB) may be a reflection of associated high-risk markers to be determined, and developing a sensitive imaging strategy for small tumors to complement immunohistochemical markers ER, PR, and HER2 may provide additional prognostic information at the molecular level. Further prospective studies will be needed to assess whether PEM FDG uptake is validated as an independent marker. This may affect treatment options and may be a marker to evaluate response to specific therapy."

PEM images from 98 newly diagnosed breast cancer patients with 100 lesions were reviewed by two physicians blinded to pathology results. Tumor FDG uptake and lesion to background (LTB) ratio levels were compared to ER, PR and HER2 receptor status. Results showed that high LTB ratio correlated with receptor status for ER-neg and PR-neg and that triple negative tumors had a higher LTB ratio. Breast tumors with higher histologic grade also had significantly higher FDG uptake than those with lower grade.

For more information: www.naviscan.com

 

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Smartphone Addiction Creates Imbalance in Brain
News | Mobile Devices | January 11, 2018
Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet,...
Emergency Radiologists See Inner Toll of Opioid Use Disorders

Rates of Imaging Positivity for IV-SUDs Complications. Image courtesy of Efren J. Flores, M.D.

News | Clinical Study | January 11, 2018
January 11, 2018 – Emergency radiologists are seeing a high prevalence of patients with complications related to opio
Minimally Invasive Treatment Provides Relief from Back Pain

Lumbar spine MRI showing disc herniation and nerve root at baseline and one month after treatment

News | Interventional Radiology | January 11, 2018
The majority of patients were pain free after receiving a new image-guided pulsed radiofrequency treatment for low back...
CT Shows Enlarged Aortas in Former Pro Football Players

3-D rendering from a cardiac CT dataset demonstrating mild dilation of the ascending aorta.

News | Computed Tomography (CT) | January 11, 2018
Former National Football League (NFL) players are more likely to have enlarged aortas, a condition that may put them at...
Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec

Size comparison between 3-D printed prosthesis implant and a penny.

News | 3-D Printing | January 11, 2018
January 11, 2018 — Researchers using...
RSNA 2017 technical exhibits, expo floor, showing new radiology technology advances.
Feature | RSNA 2017 | January 11, 2018
January 11, 2018 — Here is a list of some of the key clinical study presentations, articles on trends and videos from
Overlay Init